Actively Recruiting
Arrhythmia Detection After MI
Led by Samir Saba · Updated on 2025-07-16
200
Participants Needed
1
Research Sites
216 weeks
Total Duration
On this page
Sponsors
S
Samir Saba
Lead Sponsor
A
Abbott
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.
CONDITIONS
Official Title
Arrhythmia Detection After MI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults, age 18 years or older
- Acute myocardial infarction (STEMI or NSTEMI)
- Willing to give written informed consent
- Expected to be discharged from hospital within 7 days of AMI
- Willing to receive implantable cardiac monitor insertion within 21 days of index AMI
You will not qualify if you...
- Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device
- Pregnant
- Index AMI occurred more than 21 days ago
- Unwilling or unable to have implantable cardiac monitor inserted within 21 days post AMI
- Planned implantable cardioverter defibrillator implant, planned coronary artery bypass graft, or any open-heart surgery (e.g., for severe valve disease)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
S
Samir F Saba, MD
CONTACT
M
Melissa Enlow
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here